Home / Cancer and immune system / Vemurafenib
ATC L01EC01 · B-Raf Serine-Threonine Kinase (BRAF) Inhibitors · updated 2 Nov 2026
Vemurafenib shortage
As of 2 Nov 2026, Vemurafenib has a reported shortage in 2 of the 16 countries we track (Canada, France), covering 2 products from 1 company.
Is there a Vemurafenib shortage?
Yes. As of 2 Nov 2026, Vemurafenib is reported short in 2 of the 16 countries we track: Canada, France. No company has given a return date. New since 3 Oct 2026: Canada.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Roche ROG · SIX Swiss
Compared with similar medicines
ATC group L01EC · B-Raf Serine-Threonine Kinase (BRAF) InhibitorsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ZELBORAF (Pack of 56 tablets) | HOFFMANN-LA ROCHE LIMITED | 30 Oct 2026 | not given | Other Other (Please describe in comments) |
| FR | Zelboraf 240 mg, comprimé pelliculé limited | 1 Oct 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Vemurafenib shortage?
Yes. As of 2 Nov 2026, Vemurafenib is reported short in 2 of the 16 countries we track: Canada, France. No company has given a return date. New since 3 Oct 2026: Canada.
When will Vemurafenib be back in stock?
No return date has been given; Canada: no date given; France: no date given. These are company estimates reported to each authority.
Why is Vemurafenib in short supply?
The most common reason reported is: other. Reasons by product are listed in the table below.
Which companies have Vemurafenib shortages?
Roche.